Cadent Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,468
| Closed | -$222K | – | 130 |
|
|
2023
Q2 | $222K | Buy |
3,468
+29
| +0.8% | +$1.85K | 0.13% | 117 |
|
|
2023
Q1 | $238K | Buy |
3,439
+125
| +4% | +$8.66K | 0.11% | 104 |
|
|
2022
Q4 | $238K | Buy |
3,314
+23
| +0.7% | +$1.66K | 0.12% | 100 |
|
|
2022
Q3 | $234K | Buy |
3,291
+23
| +0.7% | +$1.64K | 0.13% | 91 |
|
|
2022
Q2 | $252K | Sell |
3,268
-64
| -2% | -$4.94K | 0.14% | 87 |
|
|
2022
Q1 | $243K | Buy |
+3,332
| New | +$243K | 0.11% | 114 |
|
|
2021
Q3 | – | Sell |
-2,998
| Closed | -$200K | – | 131 |
|
|
2021
Q2 | $200K | Sell |
2,998
-326
| -10% | -$21.7K | 0.08% | 137 |
|
|
2021
Q1 | $210K | Buy |
+3,324
| New | +$210K | 0.09% | 124 |
|